| 1 |
Wiersinga WM, Poppe KG, Effraimidis G. Hyperthyroidism: aetiology, pathogenesis, diagnosis, management, complications, and prognosis[J]. Lancet Diabetes Endocrinol, 2023, 11 (4): 282-298.
|
| 2 |
Ross DS, Burch HB, Cooper DS, et al. 2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis[J]. Thyroid, 2016, 26 (10): 1343-1421.
|
| 3 |
Farooqi S, Raj S, Koyfman A, et al. High risk and low prevalence diseases: thyroid storm[J]. Am J Emerg Med, 2023, 69: 127-135.
|
| 4 |
Chiha M, Samarasinghe S, Kabaker AS. Thyroid storm: an updated review[J]. J Intensive Care Med, 2015, 30 (3): 131-140.
|
| 5 |
中华医学会内分泌学分会，中国医师协会内分泌代谢科医师分会，中华医学会核医学分会，等.中国甲状腺功能亢进症和其他原因所致甲状腺毒症诊治指南[J].中华内分泌代谢杂志，2022，38（8）：700-748.
|
| 6 |
闫慧娴，吕朝晖.甲亢危象的识别与处理实践[J].诊断学理论与实践，2024，23（4）：354-361.
|
| 7 |
中华医学会急诊医学分会，中国医药教育协会急诊专业委员会，中国医师协会急诊医师分会，等.甲状腺危象急诊诊治专家共识[J].中华急诊医学杂志，2021，30（6）：663-670.
|
| 8 |
Mutlu U, Bektas F, Dadin S, et al. Therapeutic plasmapheresis in the management of thyrotoxicosis: a-retrospective study with emphasis on critically ill patients[J]. Endocrine, 2025, 90 (1): 157-165.
|
| 9 |
Ebrahimi P, Payab M, Taheri M, et al. Plasma exchange as a rescue therapy for treatment-resistant thyroid storm with concurrent heart failure: a literature review based on a case report[J]. Int J Emerg Med, 2024, 17 (1): 195.
|
| 10 |
Hirano R, Namazuda K, Hirata N. Double filtration plasmapheresis: review of current clinical applications[J]. Ther Apher Dial, 2021, 25 (2): 145-151.
|
| 11 |
Gerbal M, Gilly O, Joyeux MA, et al. Therapeutic plasma exchange shows greater efficacy than DFPP in reducing FT3 and FT4 levels in thyrotoxicosis due to amiodarone-induced thyrotoxicosis type 2[J]. J Clin Apher, 2025, 40 (5): e70056.
|
| 12 |
Connelly-Smith L, Alquist CR, Aqui NA, et al. Guidelines on the use of therapeutic apheresis in clinical practice — evidence-based approach from the Writing Committee of the American Society for Apheresis: the ninth special issue[J]. J Clin Apher, 2023, 38 (2): 77-278.
|
| 13 |
Tu F, Lin Y, Chen J, et al. Case report and literature review: a thyroid storm patient with severe acute hepatic failure treated by therapeutic plasma exchange and a double plasma molecular absorption system[J]. Heliyon, 2024, 10 (7): e28867.
|
| 14 |
余俊琦，卫勤明.孕晚期急性脂肪肝并发产后肝衰竭救治成功一例[J/OL].中华危重症医学杂志（电子版），2024，17（3）：254-257.
|
| 15 |
Bourcier S, Coutrot M, Kimmoun A, et al. Thyroid storm in the ICU: a retrospective multicenter study[J]. Crit Care Med, 2020, 48 (1): 83-90.
|
| 16 |
Elmenyar E, Aoun S, Al Saadi Z, et al. Data analysis and systematic scoping review on the pathogenesis and modalities of treatment of thyroid storm complicated with myocardial involvement and shock[J]. Diagnostics (Basel), 2023, 13 (19): 3028.
|
| 17 |
Chao A, Wang CH, You HC, et al. Highlighting indication of extracorporeal membrane oxygenation in endocrine emergencies[J]. Sci Rep, 2015, 5: 13361.
|
| 18 |
Li TS, Yu CH, Chen CP. Clinical features and mortality of ICU patients with thyroid storm receiving extracorporeal membrane oxygenation: a single-center experience in Taiwan[J]. Acta Cardiol Sin, 2025, 41 (6): 712-717.
|
| 19 |
Roan JN. Extracorporeal membrane oxygenation could be a game changer in patients with compromised hemodynamics induced by thyroid storm[J]. Acta Cardiol Sin, 2025, 41 (6): 718-719.
|
| 20 |
Sinha SS, Morrow DA, Kapur NK, et al. 2025 concise clinical guidance: an ACC expert consensus statement on the evaluation and management of cardiogenic shock: a report of the American College of Cardiology Solution Set Oversight Committee[J]. J Am Coll Cardiol, 2025, 85 (16): 1618-1641.
|
| 21 |
Bogerd M, Ten Berg S, Peters EJ, et al. Impella and venoarterial extracorporeal membrane oxygenation in cardiogenic shock complicating acute myocardial infarction[J]. Eur J Heart Fail, 2023, 25 (11): 2021-2031.
|
| 22 |
Caruso E, Iliadis E. Cardiogenic shock in thyroid storm: a biventricular impella (Bi-Pella) approach[J]. Clin Case Rep, 2021, 9 (3): 1104-1109.
|
| 23 |
Dhir N, Haneke T, Mixon T. Mechanical circulatory support for thyrotoxicosis-induced cardiomyopathy[J]. Proc (Bayl Univ Med Cent), 2023, 36 (2): 211-212.
|